Publicité
Publicité

STAA

STAA logo

Staar Surgical Co

22.10
USD
Sponsorisé
-0.40
-1.80%
09 janv., 15:59 UTC -5
Fermé
exchange

Après-marché

22.12

+0.02
+0.11%

STAA Rapports sur les bénéfices

Ratio de surprise positive

STAA a dépassé 32 des 40 dernières estimations.

80%

Prochain rapport

Date du prochain rapport
09 févr. 2026
Estimate for Q4 25 (Revenue/ EPS)
$77.50M
/
$0.06
Variation implicite de Q3 25 (Revenue/ EPS)
-18.20%
/
-66.67%
Variation implicite de Q4 24 (Revenue/ EPS)
+58.32%
/
-112.00%

Staar Surgical Co earnings per share and revenue

On 05 nov. 2025, STAA reported earnings of 0.18 USD per share (EPS) for Q3 25, beating the estimate of 0.16 USD, resulting in a 9.29% surprise. Revenue reached 94.73 million, compared to an expected 92.64 million, with a 2.26% difference. The market reacted with a +5.47% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analystes forecast an EPS of 0.06 USD, with revenue projected to reach 77.50 million USD, implying an baisse of -66.67% EPS, and baisse of -18.20% in Revenue from the last quarter.
FAQ
For Q3 2025, Staar Surgical Co reported EPS of $0.18, beating estimates by 9.29%, and revenue of $94.73M, 2.26% above expectations.
The stock price moved up 5.47%, changed from $25.25 before the earnings release to $26.63 the day after.
The next earning report is scheduled for 09 févr. 2026.
Based on 11 analystes, Staar Surgical Co is expected to report EPS of $0.06 and revenue of $77.50M for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité